RIZATRIPTAN BENZOATE- rizatriptan benzoate tablet United States - English - NLM (National Library of Medicine)

rizatriptan benzoate- rizatriptan benzoate tablet

jubilant cadista pharmaceuticals inc. - rizatriptan benzoate (unii: wr978s7qhh) (rizatriptan - unii:51086hbw8g) - rizatriptan 5 mg - rizatriptan benzoate tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. limitations of use - rizatriptan benzoate tablets should only be used where a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with rizatriptan benzoate tablets, the diagnosis of migraine should be reconsidered before rizatriptan benzoate tablets are administered to treat any subsequent attacks.  - rizatriptan benzoate tablets are not indicated for use in the management of hemiplegic or basilar migraine [see contraindications (4)] .  - rizatriptan benzoate tablets are not indicated for the prevention of migraine attacks.  - safety and effectiveness of rizatriptan benzoate tablets have not been established for cluster headache. rizatriptan benzoate is contraindicated in patients with: - ischemic coronary artery disease (angina pectoris, history of myocardial infarction, or documented silent

RIZATRIPTAN-AU rizatriptan (as benzoate) 10 mg orodispersible tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan-au rizatriptan (as benzoate) 10 mg orodispersible tablet blister pack

medsurge pharma pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: crospovidone; aspartame; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; calcium silicate; mannitol; flavour - rizatriptan-au is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN-AU rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan-au rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack

medsurge pharma pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - tablet, orally disintegrating - excipient ingredients: calcium silicate; magnesium stearate; aspartame; mannitol; crospovidone; microcrystalline cellulose; colloidal anhydrous silica; flavour - rizatriptan-au is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN ODT APOTEX rizatriptan (as benzoate) 10 mg orally disintegrating tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan odt apotex rizatriptan (as benzoate) 10 mg orally disintegrating tablet blister pack

arrotex pharmaceuticals pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: aspartame; crospovidone; calcium silicate; colloidal anhydrous silica; magnesium stearate; mannitol; microcrystalline cellulose; flavour - rizatriptan odt is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN ODT GH rizatriptan (as benzoate) 5 mg orally disintegrating tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan odt gh rizatriptan (as benzoate) 5 mg orally disintegrating tablet blister pack

generic health pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - tablet, orally disintegrating - excipient ingredients: mannitol; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; crospovidone; aspartame; calcium silicate; flavour - rizatriptan odt gh is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN ODT GH rizatriptan (as benzoate) 10 mg orally disintegrating tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan odt gh rizatriptan (as benzoate) 10 mg orally disintegrating tablet blister pack

generic health pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: crospovidone; aspartame; colloidal anhydrous silica; mannitol; microcrystalline cellulose; magnesium stearate; calcium silicate; flavour - rizatriptan odt gh is indicated for the acute treatment of migraine attacks with or without aura.

MYLAN-RIZATRIPTAN TABLET Canada - English - Health Canada

mylan-rizatriptan tablet

mylan pharmaceuticals ulc - rizatriptan (rizatriptan benzoate) - tablet - 5mg - rizatriptan (rizatriptan benzoate) 5mg - selective serotonin agonists

MYLAN-RIZATRIPTAN TABLET Canada - English - Health Canada

mylan-rizatriptan tablet

mylan pharmaceuticals ulc - rizatriptan (rizatriptan benzoate) - tablet - 10mg - rizatriptan (rizatriptan benzoate) 10mg - selective serotonin agonists

ACCEL-RIZATRIPTAN ODT TABLET (ORALLY DISINTEGRATING) Canada - English - Health Canada

accel-rizatriptan odt tablet (orally disintegrating)

accel pharma inc - rizatriptan (rizatriptan benzoate) - tablet (orally disintegrating) - 5mg - rizatriptan (rizatriptan benzoate) 5mg - selective serotonin agonists

ACCEL-RIZATRIPTAN ODT TABLET (ORALLY DISINTEGRATING) Canada - English - Health Canada

accel-rizatriptan odt tablet (orally disintegrating)

accel pharma inc - rizatriptan (rizatriptan benzoate) - tablet (orally disintegrating) - 10mg - rizatriptan (rizatriptan benzoate) 10mg - selective serotonin agonists